D-0340-2021 Class III Terminated
FDA drug recall D-0340-2021 was initiated by Teligent Pharma, Inc. on Feb 2, 2021 and is designated Class III. Reason for recall: Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate. The recall status is terminated (terminated Aug 15, 2024).
Recall details
- Product Type
- Drugs
- Report Date
- May 5, 2021
- Initiation Date
- Feb 2, 2021
- Termination Date
- Aug 15, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Betamethasone Dipropionate Ointment USP, 0.05% (Augmented), packaged in 15 grams tubes, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310, Distributed by: McKesson Corporation dba Sky Packaging 4971 Southbridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-996-15
Reason for recall
Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.
Distribution pattern
USA Nationwide
Code information
Lot #: 15644, Exp 5/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0340-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026